Figure 7
From: THC-induced behavioral stereotypy in zebrafish as a model of psychosis-like behavior
Potential mechanisms underlying the associations between Cannabis consumption and risks of psychosis/schizophrenia-like symptoms, with the current study’s pharmacological approaches. Δ9-tetrahydrocannabinol (THC) reduces N-methyl-D-aspartate (NMDA) release via NMDA receptor antagonism. THC also inhibits γ‐aminobutyric acid (GABA) release from interneurons in the prefrontal cortex, potentiating dopamine release. Both NMDA receptor hypoactivity and heightened dopaminergic signaling are hallmarks of schizophrenia. Pentylenetetrazol (PTZ).
